The global market for Toxicological Risk Assessments (TRA) was valued at US$ 6019 million in the year 2024 and is projected to reach a revised size of US$ 12776 million by 2031, growing at a CAGR of 9.9% during the forecast period.

Toxicological Risk Assessments (TRA) Market

Toxicological Risk Assessment (TRA) is a systematic scientific process used to evaluate the potential adverse health effects of exposure to chemicals, pharmaceuticals, consumer products, food ingredients, or environmental contaminants. The goal is to determine whether a substance poses unacceptable risks to human health or the environment under realistic exposure conditions.

North American market for Toxicological Risk Assessments (TRA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Toxicological Risk Assessments (TRA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Toxicological Risk Assessments (TRA) in Pharmaceuticals and Biotechnology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Toxicological Risk Assessments (TRA) include Eurofins Scientific, Intertek, SGS, Charles River Laboratories, Labcorp, Envigo, Merck KGaA, Bureau Veritas, Exponent, PharmaLex, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Toxicological Risk Assessments (TRA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxicological Risk Assessments (TRA).

The Toxicological Risk Assessments (TRA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Toxicological Risk Assessments (TRA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Toxicological Risk Assessments (TRA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Toxicological Risk Assessments (TRA) Market Report

Report Metric	Details
Report Name	Toxicological Risk Assessments (TRA) Market
Accounted market size in year	US$ 6019 million
Forecasted market size in 2031	US$ 12776 million
CAGR	9.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	In Vitro Toxicology Testing In Vivo Toxicology Studies
Segment by Application	Pharmaceuticals and Biotechnology Medical Devices Food and Cosmetics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eurofins Scientific, Intertek, SGS, Charles River Laboratories, Labcorp, Envigo, Merck KGaA, Bureau Veritas, Exponent, PharmaLex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Toxicological Risk Assessments (TRA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Toxicological Risk Assessments (TRA) Market growing?

Ans: The Toxicological Risk Assessments (TRA) Market witnessing a CAGR of 9.9% during the forecast period 2025-2031.

What is the Toxicological Risk Assessments (TRA) Market size in 2031?

Ans: The Toxicological Risk Assessments (TRA) Market size in 2031 will be US$ 12776 million.

Who are the main players in the Toxicological Risk Assessments (TRA) Market report?

Ans: The main players in the Toxicological Risk Assessments (TRA) Market are Eurofins Scientific, Intertek, SGS, Charles River Laboratories, Labcorp, Envigo, Merck KGaA, Bureau Veritas, Exponent, PharmaLex

What are the Application segmentation covered in the Toxicological Risk Assessments (TRA) Market report?

Ans: The Applications covered in the Toxicological Risk Assessments (TRA) Market report are Pharmaceuticals and Biotechnology, Medical Devices, Food and Cosmetics, Others

What are the Type segmentation covered in the Toxicological Risk Assessments (TRA) Market report?

Ans: The Types covered in the Toxicological Risk Assessments (TRA) Market report are In Vitro Toxicology Testing, In Vivo Toxicology Studies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Toxicological Risk Assessments (TRA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 In Vitro Toxicology Testing

1.2.3 In Vivo Toxicology Studies

1.3 Market by Application

1.3.1 Global Toxicological Risk Assessments (TRA) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceuticals and Biotechnology

1.3.3 Medical Devices

1.3.4 Food and Cosmetics

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Toxicological Risk Assessments (TRA) Market Perspective (2020-2031)

2.2 Global Toxicological Risk Assessments (TRA) Growth Trends by Region

2.2.1 Global Toxicological Risk Assessments (TRA) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Toxicological Risk Assessments (TRA) Historic Market Size by Region (2020-2025)

2.2.3 Toxicological Risk Assessments (TRA) Forecasted Market Size by Region (2026-2031)

2.3 Toxicological Risk Assessments (TRA) Market Dynamics

2.3.1 Toxicological Risk Assessments (TRA) Industry Trends

2.3.2 Toxicological Risk Assessments (TRA) Market Drivers

2.3.3 Toxicological Risk Assessments (TRA) Market Challenges

2.3.4 Toxicological Risk Assessments (TRA) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Toxicological Risk Assessments (TRA) Players by Revenue

3.1.1 Global Top Toxicological Risk Assessments (TRA) Players by Revenue (2020-2025)

3.1.2 Global Toxicological Risk Assessments (TRA) Revenue Market Share by Players (2020-2025)

3.2 Global Top Toxicological Risk Assessments (TRA) Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Toxicological Risk Assessments (TRA) Revenue

3.4 Global Toxicological Risk Assessments (TRA) Market Concentration Ratio

3.4.1 Global Toxicological Risk Assessments (TRA) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Toxicological Risk Assessments (TRA) Revenue in 2024

3.5 Global Key Players of Toxicological Risk Assessments (TRA) Head office and Area Served

3.6 Global Key Players of Toxicological Risk Assessments (TRA), Product and Application

3.7 Global Key Players of Toxicological Risk Assessments (TRA), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Toxicological Risk Assessments (TRA) Breakdown Data by Type

4.1 Global Toxicological Risk Assessments (TRA) Historic Market Size by Type (2020-2025)

4.2 Global Toxicological Risk Assessments (TRA) Forecasted Market Size by Type (2026-2031)

5 Toxicological Risk Assessments (TRA) Breakdown Data by Application

5.1 Global Toxicological Risk Assessments (TRA) Historic Market Size by Application (2020-2025)

5.2 Global Toxicological Risk Assessments (TRA) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Toxicological Risk Assessments (TRA) Market Size (2020-2031)

6.2 North America Toxicological Risk Assessments (TRA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025)

6.4 North America Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Toxicological Risk Assessments (TRA) Market Size (2020-2031)

7.2 Europe Toxicological Risk Assessments (TRA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025)

7.4 Europe Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Toxicological Risk Assessments (TRA) Market Size (2020-2031)

8.2 Asia-Pacific Toxicological Risk Assessments (TRA) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Toxicological Risk Assessments (TRA) Market Size by Region (2020-2025)

8.4 Asia-Pacific Toxicological Risk Assessments (TRA) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Toxicological Risk Assessments (TRA) Market Size (2020-2031)

9.2 Latin America Toxicological Risk Assessments (TRA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025)

9.4 Latin America Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Toxicological Risk Assessments (TRA) Market Size (2020-2031)

10.2 Middle East & Africa Toxicological Risk Assessments (TRA) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025)

10.4 Middle East & Africa Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofins Scientific

11.1.1 Eurofins Scientific Company Details

11.1.2 Eurofins Scientific Business Overview

11.1.3 Eurofins Scientific Toxicological Risk Assessments (TRA) Introduction

11.1.4 Eurofins Scientific Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.1.5 Eurofins Scientific Recent Development

11.2 Intertek

11.2.1 Intertek Company Details

11.2.2 Intertek Business Overview

11.2.3 Intertek Toxicological Risk Assessments (TRA) Introduction

11.2.4 Intertek Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.2.5 Intertek Recent Development

11.3 SGS

11.3.1 SGS Company Details

11.3.2 SGS Business Overview

11.3.3 SGS Toxicological Risk Assessments (TRA) Introduction

11.3.4 SGS Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.3.5 SGS Recent Development

11.4 Charles River Laboratories

11.4.1 Charles River Laboratories Company Details

11.4.2 Charles River Laboratories Business Overview

11.4.3 Charles River Laboratories Toxicological Risk Assessments (TRA) Introduction

11.4.4 Charles River Laboratories Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.4.5 Charles River Laboratories Recent Development

11.5 Labcorp

11.5.1 Labcorp Company Details

11.5.2 Labcorp Business Overview

11.5.3 Labcorp Toxicological Risk Assessments (TRA) Introduction

11.5.4 Labcorp Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.5.5 Labcorp Recent Development

11.6 Envigo

11.6.1 Envigo Company Details

11.6.2 Envigo Business Overview

11.6.3 Envigo Toxicological Risk Assessments (TRA) Introduction

11.6.4 Envigo Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.6.5 Envigo Recent Development

11.7 Merck KGaA

11.7.1 Merck KGaA Company Details

11.7.2 Merck KGaA Business Overview

11.7.3 Merck KGaA Toxicological Risk Assessments (TRA) Introduction

11.7.4 Merck KGaA Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.7.5 Merck KGaA Recent Development

11.8 Bureau Veritas

11.8.1 Bureau Veritas Company Details

11.8.2 Bureau Veritas Business Overview

11.8.3 Bureau Veritas Toxicological Risk Assessments (TRA) Introduction

11.8.4 Bureau Veritas Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.8.5 Bureau Veritas Recent Development

11.9 Exponent

11.9.1 Exponent Company Details

11.9.2 Exponent Business Overview

11.9.3 Exponent Toxicological Risk Assessments (TRA) Introduction

11.9.4 Exponent Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.9.5 Exponent Recent Development

11.10 PharmaLex

11.10.1 PharmaLex Company Details

11.10.2 PharmaLex Business Overview

11.10.3 PharmaLex Toxicological Risk Assessments (TRA) Introduction

11.10.4 PharmaLex Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025)

11.10.5 PharmaLex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eurofins Scientific

Intertek

SGS Ltd

Charles River Laboratories

List of Tables

Table 1. Global Toxicological Risk Assessments (TRA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of In Vitro Toxicology Testing

Table 3. Key Players of In Vivo Toxicology Studies

Table 4. Global Toxicological Risk Assessments (TRA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Toxicological Risk Assessments (TRA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Toxicological Risk Assessments (TRA) Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Toxicological Risk Assessments (TRA) Market Share by Region (2020-2025)

Table 8. Global Toxicological Risk Assessments (TRA) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Toxicological Risk Assessments (TRA) Market Share by Region (2026-2031)

Table 10. Toxicological Risk Assessments (TRA) Market Trends

Table 11. Toxicological Risk Assessments (TRA) Market Drivers

Table 12. Toxicological Risk Assessments (TRA) Market Challenges

Table 13. Toxicological Risk Assessments (TRA) Market Restraints

Table 14. Global Toxicological Risk Assessments (TRA) Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Toxicological Risk Assessments (TRA) Market Share by Players (2020-2025)

Table 16. Global Top Toxicological Risk Assessments (TRA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Toxicological Risk Assessments (TRA) as of 2024)

Table 17. Ranking of Global Top Toxicological Risk Assessments (TRA) Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Toxicological Risk Assessments (TRA) Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Toxicological Risk Assessments (TRA), Headquarters and Area Served

Table 20. Global Key Players of Toxicological Risk Assessments (TRA), Product and Application

Table 21. Global Key Players of Toxicological Risk Assessments (TRA), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Toxicological Risk Assessments (TRA) Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Toxicological Risk Assessments (TRA) Revenue Market Share by Type (2020-2025)

Table 25. Global Toxicological Risk Assessments (TRA) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Toxicological Risk Assessments (TRA) Revenue Market Share by Type (2026-2031)

Table 27. Global Toxicological Risk Assessments (TRA) Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Toxicological Risk Assessments (TRA) Revenue Market Share by Application (2020-2025)

Table 29. Global Toxicological Risk Assessments (TRA) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Toxicological Risk Assessments (TRA) Revenue Market Share by Application (2026-2031)

Table 31. North America Toxicological Risk Assessments (TRA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Toxicological Risk Assessments (TRA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Toxicological Risk Assessments (TRA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Toxicological Risk Assessments (TRA) Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Toxicological Risk Assessments (TRA) Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Toxicological Risk Assessments (TRA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Toxicological Risk Assessments (TRA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Toxicological Risk Assessments (TRA) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Toxicological Risk Assessments (TRA) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Eurofins Scientific Company Details

Table 47. Eurofins Scientific Business Overview

Table 48. Eurofins Scientific Toxicological Risk Assessments (TRA) Product

Table 49. Eurofins Scientific Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 50. Eurofins Scientific Recent Development

Table 51. Intertek Company Details

Table 52. Intertek Business Overview

Table 53. Intertek Toxicological Risk Assessments (TRA) Product

Table 54. Intertek Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 55. Intertek Recent Development

Table 56. SGS Company Details

Table 57. SGS Business Overview

Table 58. SGS Toxicological Risk Assessments (TRA) Product

Table 59. SGS Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 60. SGS Recent Development

Table 61. Charles River Laboratories Company Details

Table 62. Charles River Laboratories Business Overview

Table 63. Charles River Laboratories Toxicological Risk Assessments (TRA) Product

Table 64. Charles River Laboratories Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 65. Charles River Laboratories Recent Development

Table 66. Labcorp Company Details

Table 67. Labcorp Business Overview

Table 68. Labcorp Toxicological Risk Assessments (TRA) Product

Table 69. Labcorp Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 70. Labcorp Recent Development

Table 71. Envigo Company Details

Table 72. Envigo Business Overview

Table 73. Envigo Toxicological Risk Assessments (TRA) Product

Table 74. Envigo Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 75. Envigo Recent Development

Table 76. Merck KGaA Company Details

Table 77. Merck KGaA Business Overview

Table 78. Merck KGaA Toxicological Risk Assessments (TRA) Product

Table 79. Merck KGaA Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 80. Merck KGaA Recent Development

Table 81. Bureau Veritas Company Details

Table 82. Bureau Veritas Business Overview

Table 83. Bureau Veritas Toxicological Risk Assessments (TRA) Product

Table 84. Bureau Veritas Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 85. Bureau Veritas Recent Development

Table 86. Exponent Company Details

Table 87. Exponent Business Overview

Table 88. Exponent Toxicological Risk Assessments (TRA) Product

Table 89. Exponent Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 90. Exponent Recent Development

Table 91. PharmaLex Company Details

Table 92. PharmaLex Business Overview

Table 93. PharmaLex Toxicological Risk Assessments (TRA) Product

Table 94. PharmaLex Revenue in Toxicological Risk Assessments (TRA) Business (2020-2025) & (US$ Million)

Table 95. PharmaLex Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Toxicological Risk Assessments (TRA) Picture

Figure 2. Global Toxicological Risk Assessments (TRA) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Toxicological Risk Assessments (TRA) Market Share by Type: 2024 VS 2031

Figure 4. In Vitro Toxicology Testing Features

Figure 5. In Vivo Toxicology Studies Features

Figure 6. Global Toxicological Risk Assessments (TRA) Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Toxicological Risk Assessments (TRA) Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceuticals and Biotechnology Case Studies

Figure 9. Medical Devices Case Studies

Figure 10. Food and Cosmetics Case Studies

Figure 11. Others Case Studies

Figure 12. Toxicological Risk Assessments (TRA) Report Years Considered

Figure 13. Global Toxicological Risk Assessments (TRA) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Toxicological Risk Assessments (TRA) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Toxicological Risk Assessments (TRA) Market Share by Region: 2024 VS 2031

Figure 16. Global Toxicological Risk Assessments (TRA) Market Share by Players in 2024

Figure 17. Global Toxicological Risk Assessments (TRA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Toxicological Risk Assessments (TRA) Revenue in 2024

Figure 19. North America Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Toxicological Risk Assessments (TRA) Market Share by Country (2020-2031)

Figure 21. United States Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Toxicological Risk Assessments (TRA) Market Share by Country (2020-2031)

Figure 25. Germany Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Ireland Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Toxicological Risk Assessments (TRA) Market Share by Region (2020-2031)

Figure 33. China Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia & New Zealand Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Toxicological Risk Assessments (TRA) Market Share by Country (2020-2031)

Figure 41. Mexico Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Toxicological Risk Assessments (TRA) Market Share by Country (2020-2031)

Figure 45. Israel Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Toxicological Risk Assessments (TRA) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Eurofins Scientific Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 49. Intertek Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 50. SGS Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 51. Charles River Laboratories Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 52. Labcorp Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 53. Envigo Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 54. Merck KGaA Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 55. Bureau Veritas Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 56. Exponent Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 57. PharmaLex Revenue Growth Rate in Toxicological Risk Assessments (TRA) Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions